These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 7195712)

  • 1. Cardiovascular actions of 5,6-dimethoxy-2-(3-[(alpha-(3,4-dimethoxy) phenylethyl)-methylamino] propyl) phthalimidine (AQ-A 39), a specific bradycardic agent.
    Dämmgen J; Kadatz R; Diederen W
    Arzneimittelforschung; 1981; 31(4):666-70. PubMed ID: 7195712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular responses to increasing plasma concentrations of AQ-A 39 Cl, a new compound with negative chronotropic effects.
    Verdouw PD; Bom HP; Bijleveld RE
    Arzneimittelforschung; 1983; 33(5):702-6. PubMed ID: 6683548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AQ-A 39 (5,6-dimethoxy-2-[3[[alpha-(3,4-dimethoxy)-phenylethyl]methylamino]propyl]phtalimidine), a specific bradycardic agent with direct action on the heart.
    Kobinger W; Lillie C
    Eur J Pharmacol; 1981 Jun; 72(2-3):153-64. PubMed ID: 7250205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of two specific bradycardic agents AQ-A39 (falipamil) and AQ-AH 208 on reversible myocardial reperfusion damage in anesthetized dogs.
    Gross GJ; Daemmgen JW
    J Pharmacol Exp Ther; 1986 Aug; 238(2):422-8. PubMed ID: 3735124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The action of a new calcium antagonist 5,6-dimethoxy-2-(3 [(alpha-(3,4-dimethoxy)-phenylethyl)methylamino] propyl)-phthalimidine hydrochloride (AQ-A 39cl) on hemodynamics and ischemia parameters in exercise ECG of patients with coronary heart disease].
    Jost S; Schulz W; Kober G
    Arzneimittelforschung; 1985; 35(8):1279-82. PubMed ID: 4074444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent".
    Kobinger W; Lillie C
    Eur J Pharmacol; 1984 Sep; 104(1-2):9-18. PubMed ID: 6499920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a specific bradycardic agent (AQ-A39) and verapamil on beta-adrenergic responses in isolated guinea pig atria.
    Siegl PK; Morgan G
    Can J Physiol Pharmacol; 1987 Feb; 65(2):146-51. PubMed ID: 3032382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyses of the cardiac action of the bradycardic agent, AQ-A 39, by use of isolated, blood-perfused dog-heart preparations.
    Kawada M; Satoh K; Taira N
    J Pharmacol Exp Ther; 1984 Feb; 228(2):484-90. PubMed ID: 6694121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
    Kopia GA; Ohlstein EH; Ruffolo RR
    J Pharmacol Exp Ther; 1988 Aug; 246(2):434-40. PubMed ID: 3404441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological studies on effects of AQ-A 39 in the isolated guinea pig heart and myocardial preparations.
    Hohnloser S; Weirich J; Homburger H; Antoni H
    Arzneimittelforschung; 1982; 32(7):730-4. PubMed ID: 6889873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the new specific bradycardia agent AQ-A39 (falipamil) on coronary collateral blood flow in dogs.
    Gross GJ; Daemmgen JW
    J Cardiovasc Pharmacol; 1987 Jul; 10(1):123-7. PubMed ID: 2441148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of an antispastic, analgesic combination on blood pressure, dynamics and contractility of the left ventricle in the dog].
    Komarek J
    Arzneimittelforschung; 1976; 26(8):1583-8. PubMed ID: 1036957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities.
    Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
    J Pharmacol Exp Ther; 1985 May; 233(2):318-26. PubMed ID: 3999023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs.
    Beaughard M; Michelin MT; Tisne-Versailles J; Lamar JC
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):276-96. PubMed ID: 3493742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bradycardic effects of AQ-A 39 (falipamil) in situ and in isolated, blood-perfused dog hearts. Comparison with alinidine and verapamil.
    Ogiwara Y; Furukawa Y; Akahane K; Haniuda M; Chiba S
    Jpn Heart J; 1988 Nov; 29(6):849-61. PubMed ID: 3241338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of Hongjingtian (Gadol) injection on cardiac hemodynamics and myocardial oxygen consumption of dogs].
    Zhang ZH; Liu JS; Chu JN; Shang XH; Lin CR; Ma XB; Shi TR; Wang M; Wang YH; Li YR; Liu JH; Wu XY; Zhang XD; Zhang DS; Zhao ZH
    Zhongguo Zhong Yao Za Zhi; 2005 Jul; 30(13):1001-5. PubMed ID: 16161429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
    Pagel PS; Harkin CP; Hettrick DA; Warltier DC
    J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of sodiumnitroprusside and trimethaphan induced hypotension on haemodynamics and myocardial oxygen consumption (author's transl)].
    Hess W; Tarnow J; Patschke D; Passian J; Brückner JB
    Anaesthesist; 1976 Jan; 25(1):27-36. PubMed ID: 1259127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.